BPG is committed to discovery and dissemination of knowledge
Articles in Press
8/28/2025 6:47:53 AM | Browse: 23 | Download: 0
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Retrospective Cohort Study |
Article Title |
Added value of the albumin-bilirubin score in predicting liver-related complications and mortality in metabolic-associated steatotic liver disease
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Supatsri Sethasine, Padoemwut Teerawongsakul, Witchakorn Ruamtawee, Nutachat Treerasoradaj and Huttakan Navadurong |
Funding Agency and Grant Number |
|
Corresponding Author |
Huttakan Navadurong, Lecturer, MD, Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, 681 Samsen Road, Bangkok 10300, Thailand. huttakan.nav@nmu.ac.th |
Key Words |
Albumin-bilirubin; Metabolic-associated steatotic liver disease; Survival; Hepatic outcomes; Risk prediction |
Core Tip |
The albumin-bilirubin (ALBI) score, which was developed for hepatocellular carcinoma, showed a strong predictive value for long-term liver-related complications and all-cause mortality in patients with metabolic-associated steatotic liver disease (MASLD). In a cohort of 1163 patients with MASLD, ALBI outperformed fibrosis-4 and the existing prognostic models. Incorporating ALBI significantly improved the predictive accuracy for long-term complications and mortality, suggesting its potential role as a valuable and noninvasive tool for long-term risk stratification in MASLD. |
Citation |
Sethasine S, Teerawongsakul P, Ruamtawee W, Treerasoradaj N, Navadurong H. Added value of the albumin-bilirubin score in predicting liver-related complications and mortality in metabolic-associated steatotic liver disease. World J Gastroenterol 2025; In press |
 |
Received |
|
2025-06-17 10:17 |
 |
Peer-Review Started |
|
2025-06-17 10:19 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-07-24 08:36 |
 |
Revised |
|
2025-08-01 03:47 |
 |
Second Decision |
|
2025-08-28 02:38 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-08-28 06:47 |
 |
Articles in Press |
|
2025-08-28 06:47 |
 |
Publication Fee Transferred |
|
2025-08-03 07:24 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345